缺血后处理对大鼠肝脏缺血再灌注损伤的保护作用*

实用肝脏病杂志 ›› 2009, Vol. 12 ›› Issue (6): 414-417.

缺血后处理对大鼠肝脏缺血再灌注损伤的保护作用^*

刘书文, 张有成, 孙述霞, 李洪华, 李兴文, 赵晓宁

730050 兰州市甘肃省肿瘤医院腹外科（刘书文,李兴文,赵晓宁）; 兰州大学第二医院普外科（张有成）; 甘肃省永靖县医院病理科（孙述霞）

收稿日期:2008-09-25 出版日期:2009-12-10 发布日期:2016-05-11
通讯作者: 张有成,E-mail：zhangychmd@yahoo.com.cn
作者简介:刘书文男,36岁,医学硕士,主治医师。主要从事消化道肿瘤的诊断与治疗学研究。E-mail：liushiuwen72@yahoo.com
基金资助:
甘肃省自然科学基金资助项目（3ZS051-A25-104）

Characterization in vitro and pilot clinical observation of autologous γδT cells in patients with chronic hepatitis B

LIU Shuwen, ZHANG Youcheng, SUN Shuxia, et al

Department of Abdominal Surgery,Tumor Hospital,Lanzhou Gansu Province 730030,China

Received:2008-09-25 Online:2009-12-10 Published:2016-05-11

摘要/Abstract

摘要： 目的探讨缺血后处理对大鼠肝脏缺血再灌注损伤的保护作用。方法将75只SD大鼠随机分为假手术组、缺血再灌注组和缺血后处理组,建立大鼠肝脏局部缺血再灌注模型。检测大鼠血清、肝组织丙二醛（MDA）、超氧化物歧化酶（SOD）水平,并行肝组织病理学和超微结构检查及免疫组化法检测内源性一氧化氮合成酶（eNOS）的表达。结果与缺血再灌注组相比,缺血后处理组血清ALT和AST水平及肝组织MDA明显降低（P<0.01）,而SOD水平则显著升高（P<0.01）;肝组织病理损伤减轻,在再灌注7min时IPO组肝组织eNOS蛋白表达比IR组增强。结论缺血后处理可通过抑制再灌注后氧自由基的过量生成和再灌注损伤保护激酶通路,从而减轻肝细胞损伤。

关键词: 缺血再灌注, 肝损伤, 缺血后处理, 一氧化氮合成酶, 大鼠

Abstract: Objective To investigate the protective effect of ischemic-postconditioning （IPO） on hepatic ischemia-reperfusion injury in rats. Methods 75 Sprague-Dawley rats were randomly divided into shamoperated（S）,ischemia-reperfusion（IR） and IPO group to establish the model of acute liver ischemia-reperfusion injuries. Before persistent reperfusion,animals in IPO group were given six brief reperfusion-ischemia. The sample of blood and hepatic tissue of rats in all groups were taken for detections. Results Compared with in IR group,the concentrations of serum AST and ALT and malondialdehyde in hepatic tissues in IPO group decreased markedly（P<0.01）,while the concentrations of superoxide dismutase increased significantly（P<0.01）;the hepatic pathological damage also relieved obviously in IPO group. The expression levels of enos protein in IPO group were higher than that of IR group at the 7 min reperfusion. Conclusion IPO can attenuate hepatic ischemia-reperfusion injury by activating the prosurvival kinases of eNOS in accordance with the RISK pathway and reducing the concentrations of oxygen free radical.

Key words: Ischemia-reperfusion injury, Ischemic- postconditioning, eNOS, Rats

刘书文,张有成,孙述霞,李洪华,李兴文,赵晓宁. 缺血后处理对大鼠肝脏缺血再灌注损伤的保护作用^*[J]. 实用肝脏病杂志, 2009, 12(6): 414-417.

LIU Shuwen, ZHANG Youcheng, SUN Shuxia, et al. Characterization in vitro and pilot clinical observation of autologous γδT cells in patients with chronic hepatitis B[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2009, 12(6): 414-417.

参考文献

[1] 高峰,YAN WL,GENG YJ,等. “缺氧后处理”对大鼠缺氧—复氧心室肌细胞的保护作用[J]. 心功能杂志,1999,11（4）：241-243.
[2] ZHAO ZQ,CORVERA JS,HALKOS ME,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion：comparison with ischemic preconditioning[J]. Am J Physiol,2003,285（2）：579-588.
[3] HALKOS ME,KERENDI F,CORVERA JS,et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning[J]. Ann Thorac Surg,2004,78（3）：961-969.
[4] VINTEN-JOHANSEN J,ZHAO ZQ,JIANG R,et al. Myocardial protection in reperfusion with postconditioning[J]. Expert Rev Cardiovasc Ther,2005,3（6）：1035-1045.
[5] KOHL IV,SELZNER M,MADDEN JF,et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver[J]. Transplantation,1999,67（8）：1099.
[6] TSANG A,HAUSENLOY DJ,MACANU MM,et al. Postconditioning：A form of“modified reperfusion” protects the myocardium by activating the PI3K-Akt pathway[J]. Circ Res,2004,95（3）：230-232.
[7] YANG XM,PROCTOR JB,CUI L,et al. Multiple,brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways[J]. J Am Coll Cardiol,2004,44（5）：1103-1110.
[8] ZHAO ZQ,VINTEN-JOHANSEN J. Postconditioning：Reduction of reperfusion-induced injury[J]. Cardiovasc Res,2006,70（2）：200-211.
[9] KIN H,ZHAO ZQ,SUN HY,et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion[J]. Cardiovasc Res,2004,62（1）：74-85.
[10] KROLIKOWSKI JG,WEIHRAUCH D,BIENENGRAEBER M,et al. Role of Erk1/2,p70s6K,and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo[J]. Can J Anaesth,2006,53（2）：174-282.
[11] ARGAUD L,GATEAU-ROESCH O,RAISKY O,et al. Post-conditioning inhibits mitochondrial permeability transition [J]. Circulation,2005,111（2）：194-197.
[12] 张兴华,马晓静,李春梅,等. 缺血后处理对急性心肌梗死患者介入治疗后心肌组织水平灌注的影响[J]. 中华急诊医学杂志,2007,16（4）：362-365.

[1]	徐飞, 李伟荣. 黄芪甲苷对CCL₄所致肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 808-811.
[2]	高磊, 曹蕾, 王瑞芳, 冯丹丹, 薛娟. 人脐带间充质干细胞移植对酒精性肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 812-815.
[3]	林秋香, 王雪雯, 黄祖雄, 潘晨. 灯盏花素对肝脏缺血再灌注损伤大鼠肝脏和肠黏膜屏障功能的保护作用*[J]. 实用肝脏病杂志, 2019, 22(5): 636-639.
[4]	石小龙, 杜睿, 秦革萍, 薛华燕, 张宏鑫. 七氟醚对脓毒症大鼠肝损伤的保护作用及其作用机制研究*[J]. 实用肝脏病杂志, 2019, 22(5): 640-643.
[5]	吴欣, 郭杨志, 杜霄壤, 吴孟晋, 朱云, 冯兴中. 75例中药诱导的肝损伤患者临床特征分析*[J]. 实用肝脏病杂志, 2019, 22(5): 668-671.
[6]	刘杏, 赵树立, 张殿隆. 七氟烷吸入时机对肝脏部分切除术患者肝脏缺血再灌注损伤的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 728-731.
[7]	王艳, 苏峰, 李园园, 李舒. 蜂毒溶血肽改善非酒精性脂肪肝大鼠肝组织脂肪沉积作用及其机制研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 474-477.
[8]	周丽云, 李校天, 李丽, 杨俊超. 1,25（OH）₂D₃通过调节miR-146a水平抑制大鼠肝纤维化的体内和体外观察[J]. 实用肝脏病杂志, 2019, 22(3): 333-336.
[9]	杜敏, 周敏, 纪宗淑, 刘海燕, 汤睿, 周亮, 高智. 脓毒症并发肝损伤患者临床特征及其危险因素分析[J]. 实用肝脏病杂志, 2019, 22(3): 369-372.
[10]	彭新健, 肖玉辉, 许斯鼎, 石荣跃, 王耀政, 王瑜琳. 放射性肝损伤患者肝脏磁共振扩散加权成像表现特征分析[J]. 实用肝脏病杂志, 2019, 22(3): 373-376.
[11]	刘立伟,赵新颜. 药物性肝损伤临床与组织病理学特点[J]. 实用肝脏病杂志, 2019, 22(2): 160-163.
[12]	黄春洋,单晶,廖慧钰,黄云丽,韩莹,张小丹,杜晓菲,任美欣,边新渠,刘燕敏. 甲基强的松龙治疗药物性肝损伤患者临床及实验室特点分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 208-211.
[13]	吴秀欣,张惠勇,张凯. 抗结核药物所致肝损伤患者血浆MiRNA-4284水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(2): 212-215.
[14]	宋芳娇,朱冰,吕飒,田华,王海波,辛绍杰,游绍莉. 314例药物性肝衰竭患者临床特征分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 216-219.
[15]	郭丽平, 张成宏, 宁宝烁, 许敏, 徐贝贝, 王雪, 李异玲. 一种新生大鼠肝细胞分离改良方法的建立^*[J]. 实用肝脏病杂志, 2019, 22(1): 17-20.